Home › Biliary Tract Cancer › Virginia › Arlington
Biliary Tract Cancer clinical trials in Arlington, VA
9 studies for Biliary Tract Cancer are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RecruitingPhase 1
- NEXT Virginia, Fairfax · 11 mi away
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RecruitingPhase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi away
CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Clinical Study Site, Fairfax · 11 mi away
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RecruitingPhase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi away
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RecruitingPhase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 mi away
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
RecruitingPhase 1
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 262771, Fairfax · 11 mi away
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
RecruitingPhase 3
- Research Site, Fairfax · 11 mi away
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RecruitingPhase 1
- Virginia Cancer Specialists, Fairfax · 11 mi away
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
RecruitingPhase 1/2
- NEXT Oncology, Fairfax · 11 mi away
Biliary Tract Cancer trials in other cities
- Houston, TX19 studies
- Los Angeles, CA12 studies
- New York City, NY11 studies
- Nashville, TN11 studies
- Boston, MA11 studies
- Baltimore, MD9 studies
- Dallas, TX8 studies
- Baldwin Park, CA7 studies
- San Antonio, TX7 studies
- Columbus, OH6 studies
- Washington, DC6 studies
- Madison, WI6 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer111 studies
- Colorectal Cancer54 studies
- Metastatic Cancer52 studies
- Cancer (all types)52 studies
- Breast Cancer50 studies
- Ovarian Cancer47 studies
- Lung Cancer42 studies
- Endometrial Cancer41 studies
- Pancreatic Cancer33 studies
- Head and Neck Squamous Cell Carcinoma29 studies
- Small Cell Lung Cancer22 studies
- Triple-Negative Breast Cancer21 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.